Literature DB >> 4609380

Delay in progression of malignant lymphoma after BCG vaccination.

J E Sokal, C W Aungst, M Snyderman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4609380     DOI： 10.1056/NEJM197412052912305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Therapeutic targeting of trained immunity.

Authors:  Willem J M Mulder; Jordi Ochando; Leo A B Joosten; Zahi A Fayad; Mihai G Netea
Journal:  Nat Rev Drug Discov       Date:  2019-07       Impact factor: 84.694

2.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

3.  BCG and cancer.

Authors: 
Journal:  Can Med Assoc J       Date:  1975-10-18       Impact factor: 8.262

Review 4.  Tumour immunology and the gut.

Authors:  K C Calman
Journal:  Gut       Date:  1975-06       Impact factor: 23.059

5.  Bacille Calmette-Guérin as maintenance therapy for non-Hodgkin's lymphoma.

Authors:  J W Thomas; I H Plenderleith; S Landi; V E Basco; D V Clements
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.